Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

STU:4E2 (USA)  
€ 2.76 (0%) Jun 14
At Loss
P/B:
1.26
Market Cap:
€ 84.58M ($ 90.53M)
Enterprise V:
€ 6.72M ($ 7.19M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Relmada Therapeutics Inc Operating Data

Relmada Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Relmada Therapeutics Inc (STU:4E2) Operating Data Charts